Carol M. Black
The Royal Free Hospital · 205 works · 18,980 citations · h-index 66
Top works
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
- Bosentan Therapy for Pulmonary Arterial Hypertension
- Interstitial Lung Disease in Systemic Sclerosis
- Survival with first-line bosentan in patients with primary pulmonary hypertension
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
- Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome
- Fibrosing Alveolitis Associated with Systemic Sclerosis Has a Better Prognosis Than Lone Cryptogenic Fibrosing Alveolitis
- Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist
- Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.
- The Predictive Value of Appearances on Thin-section Computed Tomography in Fibrosing Alveolitis
- A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
- Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
- A disease severity scale for systemic sclerosis: development and testing.
- Treatment of systemic vasculitis with pooled intravenous immunoglobulin
- CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling
- Structural Features of Interstitial Lung Disease in Systemic Sclerosis
- CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia
- Scleroderma renal crisis: patient characteristics and long-term outcomes
- Prediction of five-year survival following presentation with scleroderma: Development of a simple model using three disease factors at first visit
- European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes